Skip to main content
Heranba Industries Limited logo

Heranba Industries Limited — Investor Relations & Filings

Ticker · HERANBA ISIN · INE694N01015 LEI · 335800OPXIEPYCNRWS37 BSE.NS Manufacturing
Open in API
Filings indexed 442 across all filing types
Latest filing 2024-10-15 Regulatory Filings
Country IN India
Listing BSE.NS HERANBA

About Heranba Industries Limited

https://www.heranba.co.in/

Heranba Industries Limited specializes in the manufacturing and marketing of synthetic pyrethroids and their intermediates. The company operates an integrated business model spanning the production of technicals, formulations, and branded products. Its extensive portfolio includes key active ingredients such as Cypermethrin, Deltamethrin, Alpha Cypermethrin, and Permethrin, catering to agriculture, public health, and animal health sectors. With multiple manufacturing facilities and dedicated R&D capabilities, the company provides a wide range of insecticides, herbicides, and fungicides. Heranba maintains a global footprint, supplying products to over sixty countries while ensuring quality control from intermediate stages to final crop protection solutions.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2024-10-15 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2024. It is a compliance certificate from the company's Registrar and Share Transfer Agent confirming that the regulation is not applicable as all shares are in demat form and no rematerialisation or dematerialisation requests were received during the quarter. The document is addressed to stock exchanges and is a regulatory compliance filing rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data, nor is it an announcement of a report publication. It is primarily a certification letter related to regulatory compliance. Therefore, according to the Certification Rule and the fallback category for such regulatory compliance documents, the appropriate classification is Regulatory Filings (RNS). The document length is short (2282 characters), consistent with a certification or compliance letter rather than a full report.
2024-10-15 English
Press Release
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the commencement of commercial production at a new unit of a wholly owned subsidiary. It is addressed to stock exchanges under SEBI regulations and includes forward-looking statements about expected revenue and production capacity. There are no financial statements, detailed financial analysis, or regulatory filings such as annual or quarterly reports. The document is an update on operational progress and business development, typical of a Capital/Financing Update or operational announcement. Given the nature of the announcement about starting commercial production and expected revenue generation, it fits best under Capital/Financing Update (CAP). The document length is 4632 characters, which is sufficient for a detailed announcement but does not contain financial results or management discussion. Therefore, the classification is CAP with high confidence.
2024-10-08 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the closure of the trading window for insiders in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. It specifies the period during which designated persons and connected persons are prohibited from trading securities, linked to the upcoming declaration of quarterly financial results for the period ended September 30, 2024. The document does not contain any financial data, results, or detailed report content but is an announcement related to regulatory compliance and insider trading restrictions. It is not a financial report, earnings release, or management discussion but a regulatory filing informing the market and exchanges about the trading window closure. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-09-26 English
Shareholders meeting
Regulatory Filings
2024-09-14 English
Shareholders meeting
AGM Information Classification · 100% confidence The document is a detailed summary of the proceedings of the 32nd Annual General Meeting (AGM) of Heranba Industries Limited held on September 12, 2024. It includes information about the meeting date, venue, attendees including board members and auditors, the business transacted including ordinary and special resolutions, voting procedures, and the chairman's speech. The document specifically states it is a "Summary of Proceedings of the 32nd Annual General Meeting" and references the Annual Report and Auditor's Report as having been circulated but does not contain the reports themselves. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or summaries of the meeting proceedings. The document is not the Annual Report itself, nor is it a voting results declaration or a proxy solicitation. Therefore, the correct classification is AGM Information (AGM-R).
2024-09-12 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.